Conditions: Metabolic Syndrome
Keywords: plasma lipid profile metabolic syndrome
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 97
Healthy volunteers: no

Brief summary:
The primary objective is to evaluate the efficacy of rosuvastatin therapy on plasma lipid profile (Low Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), total cholesterol, triglyceride) in patients with metabolic syndrome.

Detailed description:

Arms:
arm 1: medication start dose is 10mg. After 6 weeks of treatment will be force-titrated to 20mg.

Interventions: intervention 1: rosuvastatin
Intervention descriptions: intervention 1: medication start dose is 10mg. After 6 weeks of treatment will be force-titrated to 20mg.

Protocol document: